Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-18

FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Dr. Reddys Laboratories Inc.)

View source ↗

Summary

FDA approved a supplemental application for Bupropion Hydrochloride SR from Dr. Reddy's Laboratories, authorizing its continued marketing as a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride SR (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE SR (BUPROPION HYDROCHLORIDE)